U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a new federal initiative to build a comprehensive autism data platform using Medicare and Medicaid records. Designed to study the causes of autism spectrum disorder (ASD), the platform will integrate claims data, electronic health records, and data from wearable health devices, according to the Department of Health and Human Services (HHS).
The National Institutes of Health (NIH) and the Centers for Medicare and Medicaid Services (CMS) will collaborate on the effort, which is part of a broader $50 million research initiative to investigate potential environmental and medical causes of autism. Kennedy stated the project aims to provide "honest answers families have waited far too long to hear," despite his controversial history promoting a debunked link between vaccines and autism.
HHS said the platform will help researchers analyze autism diagnoses, treatment outcomes, healthcare access disparities, and the financial impact on families. However, experts like Dr. Helen Tager-Flusberg of Boston University argue the focus does not directly address autism’s root causes. She also noted that an existing NIH autism database recently went offline without explanation, raising concerns about transparency.
The project has sparked privacy questions, as HHS has not confirmed whether the database will be anonymous or voluntary. Autism researcher Eric Rubenstein noted that Medicaid and Medicare data offer insights into health disparities but lack environmental exposure data, which Kennedy claims he will explore.
Autism rates have surged in recent years, with the CDC reporting 1 in 31 U.S. 8-year-olds diagnosed in 2022. While Kennedy aims to identify autism’s causes by September, scientists emphasize that autism likely stems from a complex mix of genetic and environmental factors. Critics warn against oversimplifying this ongoing scientific challenge.


CFPB to Review Anti-Discrimination Policies and Fair Lending Rules Amid Policy Shift
U.S. State Department Reverts to Times New Roman in Push for “Professionalism”
Australia Enforces World-First Social Media Age Limit as Global Regulation Looms
U.S. Military Bill Seeks to End Dependence on China for Display Technology by 2030
U.S. Justice Department Orders Intensified Probe Into Antifa and Domestic Extremist Groups
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Australia’s Under-16 Social Media Ban Sparks Global Debate and Early Challenges
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Trump Criticizes Insurers as Debate Over Extending Obamacare Subsidies Intensifies
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only
U.S. Greenlights Nvidia H200 Chip Exports to China With 25% Fee
U.S. Homeland Security Ends TSA Union Contract, Prompting Legal Challenge
Trump Set to Begin Final Interviews for Next Federal Reserve Chair
DOJ Sues Loudoun County School Board Over Transgender Locker Room Policy
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure 



